Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors

Authors:: Chen Mei; Xue Zhang; Yan Zhi; Zhixuan Liang; Haojun Xu; Zhenyi Liu; Ying Liu; Yanli Lyu; Hongjun Wang

Reference:: International Journal of Molecular Sciences; 2024; 25; 670

DOI:: 10.3390/ijms25010670

See Abstract

Key Words:: PD-L1; mammary tumor; U27; isorhamnetin; EGFR/STAT3/PD-L1

Back to index